BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the recipient of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 592,700 shares, a drop of 74.1% from the March 31st total of 2,290,000 shares. Currently, 1.9% of the shares of the company are short sold. Based on an average daily trading volume, of 5,510,000 shares, the short-interest ratio is currently 0.1 days.
BIOLASE Price Performance
BIOLASE stock traded up $0.00 during trading on Friday, reaching $0.15. The company had a trading volume of 663,098 shares, compared to its average volume of 4,451,342. BIOLASE has a 52 week low of $0.13 and a 52 week high of $32.09. The firm’s 50-day simple moving average is $0.15 and its 200 day simple moving average is $0.83. The company has a debt-to-equity ratio of 34.06, a current ratio of 1.26 and a quick ratio of 0.68.
BIOLASE (NASDAQ:BIOL – Get Free Report) last announced its earnings results on Thursday, March 21st. The medical technology company reported ($1.76) EPS for the quarter. BIOLASE had a negative return on equity of 555.22% and a negative net margin of 41.97%. The company had revenue of $13.49 million during the quarter.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on BIOLASE
About BIOLASE
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Featured Stories
- Five stocks we like better than BIOLASE
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is a Stock Market Index and How Do You Use Them?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.